Licogliflozin
Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor.
Product Specifications
CAS Number
[1291094-73-9]
Product Name Alternative
LIK066
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
SGLT
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Licogliflozin.html
Purity
98.03
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 2 mg/mL (ultrasonic)
Smiles
O[C@H]1[C@H](C2=CC(CC3=CC=C4C(OCCO4)=C3)=C(CC)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O
Molecular Formula
C23H28O7
Molecular Weight
416.46
Precautions
H302, H315, H319, H335
References & Citations
[1]Monica A. Konerman, et al. Overview of Clinical Treatment Trials for NASH.Curr Hepatol Rep. 2017 Dec;16 (4) : 366-373.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
SGLT1; SGLT2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MRFAP1L1, ID (MRFAP1L1, MORF4 family-associated protein 1-like 1) (MaxLight 550) discontinued
